Insiders · Profile

Fried Robert N

Chief Executive Officer at Niagen Bioscience · Director at Fluent. Filing since 29 Jan 2016. CIK 0001417952

Company
Date
Role
Action
Shares
Amount
Of holding
31 May 2023
Chief Executive Officer
Bought
7,000
$9.94K
8.0%
30 Sep 2022
Cheif Executive Officer
Bought
80,000
$100.00K
9.0%
16 Mar 2022
CEO
Bought
25,000
$54.00K
39.7%
13 May 2021
CEO
Bought
10,000
$66.50K
18.9%
19 May 2020
CEO
Bought
1,000
$4.69K
0.1%
14 Nov 2019
CEO
Bought
10,000
$30.90K
0.7%
23 Aug 2019
CEO
Bought
2,500
$10.08K
0.2%
21 May 2019
CEO
Bought
2,253
$9.98K
0.2%
15 Mar 2019
CEO
Bought
5,000
$19.00K
0.4%
15 Aug 2017
PRESIDENT, CHIEF STRATEGY OFF.
Bought
10,000
$31.50K
1.7%
7 Nov 2016
Director
Bought
2,000
$7.50K
0.6%
1 Sep 2016
Director
Bought
15,000
$50.85K
28.9%
29 Jan 2016
Director
Sold, plan not stated
5,063
$6.38K
3.1%
13 decisions on file.